Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Mağaza
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Isı Haritası
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
F
FHLC
Fidelity MSCI Health Care Index ETF
72.2
8
USD
-0.76%
Sektör:
Finansal
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
-0.76%
Aylık Değişim
+3.85%
6 Aylık Değişim
-4.40%
Yıllık Değişim
+16.28%
Önceki Kapanış
72.8
3
Open
72.2
0
Düşük
72.1
9
High
72.3
0
Hacim
43
Piyasalar
US ETFs
FHLC
Tam grafiği aç
Full chart
Genel Bakış
Tüm yatırımlar
Isı Haritası
En büyük yatırımlar
Market Value
Shares
Weight %
DNA
Ginkgo Bioworks Holdings Inc
115.874460000 K
12.918000000 K
0.004098095%
ARDT
Ardent Health Inc
100.850480000 K
12.344000000 K
0.003566746%
GDRX
GoodRx Holdings Inc
89.319960000 K
39.348000000 K
0.003158950%
LENZ
LENZ Therapeutics Inc
79.716980000 K
5 039.000000000
0.002819325%
CTEV
Claritev Corp
67.465440000 K
2 484.000000000
0.002386028%
Chicago Mercantile Exchange
4 696.990000000
4.000000000
0.000166117%
CONTRA AKOUOS INC
2 253.970000000
11.863000000 K
0.000079715%
OMNIAB INC
1 567.450000000
3 335.000000000
0.000055435%
CONTRA CHINOOK THERAPE
0.240000000
24.218000000 K
0.000000008%
CONTRA AKERO THERAPEUT
0.220000000
22.341000000 K
0.000000008%
1
...
10
11
12
13
14
15
16
17
Haberler
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil